Gordon Baxter has held several senior research positions within the pharmaceutical industry, working with a variety of companies, including Glaxo, Syntex and SmithKline Beecham. He was the founding entrepreneur of Pharmagene plc and held positions as Chief Scientific Officer, Chief Operating Officer and Non-Executive Director with the Company until its successful flotation on the London Stock Exchange in July 2000. He has a successful track record of innovation in drug discovery and has contributed to the development of several marketed drugs.

Link to Biowisdom here

The ERBI IT Special Interest Group is sponsored by